BKI Investment Company Limited (ASX:BKI)

CTI BioPharma Statistics

Total Valuation

ASX:BKI has a market cap or net worth of AUD 1.53 billion. The enterprise value is 1.43 billion.

Market Cap	1.53B
Enterprise Value	1.43B

Important Dates

The last earnings date was Monday, July 21, 2025.

Earnings Date	Jul 21, 2025
Ex-Dividend Date	Aug 5, 2025

Share Statistics

ASX:BKI has 807.13 million shares outstanding. The number of shares has increased by 0.66% in one year.

Current Share Class	807.13M
Shares Outstanding	807.13M
Shares Change (YoY)	+0.66%
Shares Change (QoQ)	-0.16%
Owned by Insiders (%)	4.78%
Owned by Institutions (%)	1.67%
Float	683.87M

Valuation Ratios

The trailing PE ratio is 24.65.

PE Ratio	24.65
Forward PE	n/a
PS Ratio	22.00
PB Ratio	1.06
P/TBV Ratio	1.06
P/FCF Ratio	n/a
P/OCF Ratio	23.72
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	23.07
EV / Sales	20.58
EV / EBITDA	n/a
EV / EBIT	21.36
EV / FCF	n/a

Financial Position

The company has a current ratio of 31.03

Current Ratio	31.03
Quick Ratio	31.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 4.40% and return on invested capital (ROIC) is 2.97%.

Return on Equity (ROE)	4.40%
Return on Assets (ROA)	2.72%
Return on Invested Capital (ROIC)	2.97%
Return on Capital Employed (ROCE)	4.23%
Revenue Per Employee	34.67M
Profits Per Employee	30.93M
Employee Count	2
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

In the past 12 months, ASX:BKI has paid 6.07 million in taxes.

Income Tax	6.07M
Effective Tax Rate	8.93%

Stock Price Statistics

The stock price has increased by +6.78% in the last 52 weeks. The beta is 0.36, so ASX:BKI's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	+6.78%
50-Day Moving Average	1.76
200-Day Moving Average	1.71
Relative Strength Index (RSI)	81.34
Average Volume (20 Days)	362,423

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:BKI had revenue of AUD 69.33 million and earned 61.86 million in profits. Earnings per share was 0.08.

Revenue	69.33M
Gross Profit	69.33M
Operating Income	66.80M
Pretax Income	67.93M
Net Income	61.86M
EBITDA	n/a
EBIT	66.80M
Earnings Per Share (EPS)	0.08

Balance Sheet

The company has 98.44 million in cash and n/a in debt, giving a net cash position of 98.44 million or 0.12 per share.

Cash & Cash Equivalents	98.44M
Total Debt	n/a
Net Cash	98.44M
Net Cash Per Share	0.12
Equity (Book Value)	1.44B
Book Value Per Share	1.79
Working Capital	105.41M

Cash Flow

Operating Cash Flow	64.32M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 96.34% and 89.22%.

Gross Margin	100.00%
Operating Margin	96.34%
Pretax Margin	97.97%
Profit Margin	89.22%
EBITDA Margin	n/a
EBIT Margin	96.34%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 4.33%.

Dividend Per Share	0.08
Dividend Yield	4.33%
Dividend Growth (YoY)	0.64%
Years of Dividend Growth	n/a
Payout Ratio	96.85%
Buyback Yield	-0.66%
Shareholder Yield	3.68%
Earnings Yield	4.06%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:BKI has an Altman Z-Score of 6.47 and a Piotroski F-Score of 4.

Altman Z-Score	6.47
Piotroski F-Score	4